Short Note
Version 1
Preserved in Portico This version is not peer-reviewed
Cannabidiol, NegEnt and Panic Disorder
Version 1
: Received: 25 February 2023 / Approved: 27 February 2023 / Online: 27 February 2023 (09:07:43 CET)
How to cite: Scrimali, T. Cannabidiol, NegEnt and Panic Disorder. Preprints 2023, 2023020464. https://doi.org/10.20944/preprints202302.0464.v1. Scrimali, T. Cannabidiol, NegEnt and Panic Disorder. Preprints 2023, 2023020464. https://doi.org/10.20944/preprints202302.0464.v1.
Abstract
The article presents the potential of liposomal cannabidiol in the treatment of Panic Disorder, when used in integration with Complex Cognitive Psychotherapy. The advantages of the integrated treatment, developed by the Author, and based on the use of liposomal cannabidiol combined with cognitive psychotherapy, are discussed. A new and original tool is presented and described, developed, and tested for the first time by the Author and called NegEnt Panic Blocker.
Keywords
cannabidiol; liposomal cannabidiol; NegEnt; panic disorders; cognitive psychotherapy; alprazolam
Subject
MEDICINE & PHARMACOLOGY, Psychiatry & Mental Health studies
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
